Navigation Links
Stereotaxis Announces Global Initial Training Site at University of Chicago
Date:12/30/2010

ST. LOUIS, Dec. 30, 2010 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that starting in 2011, Stereotaxis will utilize the Remote Magnetic Navigation System in the electrophysiology (EP) lab at the University of Chicago Medical Center to train clinicians planning to install Stereotaxis at their own centers.

With adoption of Stereotaxis' Remote Magnetic Navigation System growing steadily, there is significant new demand for training with the system from clinicians worldwide. The Heart Rhythm Center at the University of Chicago (UCMC) is a world-leader in the care of patients with irregular heartbeats.

"The Heart Rhythm Center at the University of Chicago is one of the busiest university-based interventional programs in the greater Chicago area, providing the latest in diagnostic and treatment modalities," said Dr. Martin Burke, Acting Chief of Cardiology. "With Stereotaxis, we have the ability to care for people with the most complex irregular heartbeats."

This arrangement between UCMC and Stereotaxis creates a unique opportunity for electrophysiologists and other interventionalists who need training in magnetic navigation. UCMC will dedicate its Stereotaxis lab for training with phantom models for discrete periods, giving the Stereotaxis Clinical Training Directors the ability to provide guidance free from the distractions that are common when clinicians engage in training in their own facilities.

"Our experience shows that a well-trained EP clinical team adopts magnetic navigation much more rapidly in the year following the system's installation," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "So we are focused on developing our clinical training programs as a key business strategy. With our recently launched Odyssey Interventional Network, the Global Initial Training Site demonstrates Stereotaxis' commitment to enhancing the standard of interventional care with innovative education and training solutions. We are excited and grateful to be working with Dr. Burke on this important venture."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.

Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey™ Enterprise Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed.  Odyssey™ then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.

The core components of the Stereotaxis systems have received regulatory clearance in the U.S., Europe, Canada and elsewhere. For more information, please visit www.stereotaxis.com and www.odysseyexperience.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, the effect of global  economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stereotaxis Completes $40 Million Credit Facility
2. Stereotaxis Announces Public Offering of Common Stock
3. Stereotaxis Receives Commitment to Increase and Extend Credit Facility
4. Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program
5. Stereotaxis Reports Third Quarter Financial Results
6. Stereotaxis Appoints Industry Veteran as Head of EMEA Sales and Operations
7. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
8. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
9. Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year
10. Stereotaxis to Present at the JMP Securities Healthcare Conference
11. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" or ... today that it entered into collaboration with Takeda ... the treatment of NASH and other gastrointestinal (GI) ... LUNAR™ and UNA Oligomer chemistry. The financial terms ... commitment to and expertise in GI disorders, we ...
(Date:12/6/2016)... 6, 2016 A new study released today ... 340B) projects the 340B Drug Pricing Program will continue to ... it is expected to exceed $23 billion in total purchases ... purchases surpass current Medicare Part B drug reimbursement purchases over ... – based on analysis of data on total drug purchases ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... ... An inventor, from Talladega, Ala., thought there needed to be a more ... , The SLING-VEST provides an effective way to support and align the arm or ... result, it helps to reduce discomfort and shifting. The invention features an effective design ...
(Date:12/6/2016)... ... ... Mount Sinai Health System today announced the creation of the Medical Modeling ... order 3D models for their cases. Virtual reality, simulation, and 3D printing services ... resource will be the first of its kind catering to the unique patient-specific modeling ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):